ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE)
NCT04453839
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
OTHER
Sponsor class
Conditions
Critical COVID-19 With Respiratory Failure
Interventions
DRUG:
ZYESAMI (aviptadil acetate)
Sponsor
APR Applied Pharma Research s.a.